Peak6 Investments LLC Amylyx Pharmaceuticals, Inc. Call Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$12.07 - $18.46 $362,100 - $553,800
30,000 New
30,000 $441,000
Q2 2023

Aug 11, 2023
SELL
$20.98 - $31.42 $62,940 - $94,260
-3,000 Reduced 14.49%
17,700 $381,000
Q1 2023

May 12, 2023
BUY
$27.71 - $40.93 $573,597 - $847,251
20,700 New
20,700 $607,000
Q3 2022

Nov 14, 2022
BUY
$17.15 - $30.92 $939,819 - $1.69 Million
54,800 New
54,800 $1.54 Million

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $310M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email